Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
Efficacy, Safety, and Tolerability of two administrations of COMP360 in participants with treatment-resistant depression (TRD)
Epistemonikos ID: a70a6b69d344b7c6d2db3d5f6141e98f3d92a61f
First added on: Feb 19, 2024